| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 10.40B | 11.42B | 14.10B | 7.13B | 4.41B | 1.04B |
| Gross Profit | 2.44B | 2.71B | 14.10B | 3.13B | 4.41B | 1.04B |
| EBITDA | 1.30B | 1.56B | 1.78B | 2.21B | 649.00M | -32.45M |
| Net Income | 483.00M | 766.00M | 1.21B | 796.00M | 499.00M | -112.00M |
Balance Sheet | ||||||
| Total Assets | 156.06B | 157.18B | 139.95B | 61.64B | 43.46B | 11.49B |
| Cash, Cash Equivalents and Short-Term Investments | 22.90B | 25.93B | 70.44B | 4.31B | 5.08B | 393.00M |
| Total Debt | 5.69B | 5.69B | 4.54B | 3.74B | 3.80B | 693.00M |
| Total Liabilities | 139.17B | 139.26B | 126.88B | 52.79B | 39.19B | 10.06B |
| Stockholders Equity | 16.56B | 17.59B | 12.23B | 8.70B | 4.26B | 1.44B |
Cash Flow | ||||||
| Free Cash Flow | 2.50B | 2.54B | 4.53B | 1.37B | 620.00M | 1.58B |
| Operating Cash Flow | 2.58B | 2.61B | 4.57B | 1.51B | 644.00M | 1.58B |
| Investing Cash Flow | -8.27B | -9.67B | 1.43B | -1.81B | -4.88B | -3.86B |
| Financing Cash Flow | 7.65B | 7.81B | 1.92B | 2.46B | 5.99B | 2.64B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | C$18.81B | 16.49 | 13.19% | 3.59% | 17.16% | 22.85% | |
76 Outperform | C$15.66B | 15.34 | 12.80% | 2.11% | -1.40% | 14.51% | |
74 Outperform | C$21.00B | 6.95 | 16.02% | ― | -25.81% | ― | |
71 Outperform | C$56.96B | 17.36 | 12.98% | 4.11% | -10.77% | -1.88% | |
70 Outperform | C$5.95B | 5.14 | 13.53% | 892.19% | 5.93% | 7.86% | |
70 Outperform | C$8.31B | 9.85 | 6.52% | 0.36% | 2.88% | 32.70% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |